Literature DB >> 20855214

2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.

Deniz Tasdemir1, David Sanabria, Ina L Lauinger, Alice Tarun, Rob Herman, Remo Perozzo, Mire Zloh, Stefan H Kappe, Reto Brun, Néstor M Carballeira.   

Abstract

Acetylenic fatty acids are known to display several biological activities, but their antipan class="Disease">malarial activity has remained unexplored. In this study, we synthesized the 2-, 5-, 6-, and 9-hexadecynoic acids (HDAs) and evaluated their in vitro activity against erythrocytic (blood) stages of Plasmodium falciparum and liver stages of Plasmodium yoelii infections. Since the type II fatty acid biosynthesis pathway (PfFAS-II) has recently been shown to be indispensable for liver stage malaria parasites, the inhibitory potential of the HDAs against multiple P. falciparum FAS-II (PfFAS-II) elongation enzymes was also evaluated. The highest antiplasmodial activity against blood stages of P. falciparum was displayed by 5-HDA (IC(50) value 6.6 μg/ml), whereas the 2-HDA was the only acid arresting the growth of liver stage P. yoelii infection, in both flow cytometric assay (IC(50) value 2-HDA 15.3 μg/ml, control drug atovaquone 2.5 ng/ml) and immunofluorescence analysis (IC(50) 2-HDA 4.88 μg/ml, control drug atovaquone 0.37 ng/ml). 2-HDA showed the best inhibitory activity against the PfFAS-II enzymes PfFabI and PfFabZ with IC(50) values of 0.38 and 0.58 μg/ml (IC(50) control drugs 14 and 30 ng/ml), respectively. Enzyme kinetics and molecular modeling studies revealed valuable insights into the binding mechanism of 2-HDA on the target enzymes. All HDAs showed in vitro activity against Trypanosoma brucei rhodesiense (IC(50) values 3.7-31.7 μg/ml), Trypanosoma cruzi (only 2-HDA, IC(50) 20.2 μg/ml), and Leishmania donovani (IC(50) values 4.1-13.4 μg/ml) with generally low or no significant toxicity on mammalian cells. This is the first study to indicate therapeutic potential of HDAs against various parasitic protozoa. It also points out that the malarial liver stage growth inhibitory effect of the 2-HDA may be promoted via PfFAS-II enzymes. The lack of cytotoxicity, lipophilic nature, and calculated pharmacokinetic properties suggests that 2-HDA could be a useful compound to study the interaction of fatty acids with these key P. falciparum enzymes.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855214      PMCID: PMC2981824          DOI: 10.1016/j.bmc.2010.08.055

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  43 in total

1.  VEGA--an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming.

Authors:  Alessandro Pedretti; Luigi Villa; Giulio Vistoli
Journal:  J Comput Aided Mol Des       Date:  2004-03       Impact factor: 3.686

2.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Authors:  Olivier Silvie; Eric Rubinstein; Jean-François Franetich; Michel Prenant; Elodie Belnoue; Laurent Rénia; Laurent Hannoun; Wijnand Eling; Shoshana Levy; Claude Boucheix; Dominique Mazier
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

Review 3.  Imaging liver-stage malaria parasites.

Authors:  Kathleen E Rankin; Stefanie Graewe; Volker T Heussler; Rebecca R Stanway
Journal:  Cell Microbiol       Date:  2010-02-19       Impact factor: 3.715

4.  Antifungal properties of 2-alkynoic acids and their methyl esters.

Authors:  H Gershon; L Shanks
Journal:  Can J Microbiol       Date:  1978-05       Impact factor: 2.419

5.  Effect of long-chain fatty acids on some trypanosomatid flagellates.

Authors:  L V Cunningham; B H Kazan; S S Kuwahara
Journal:  J Gen Microbiol       Date:  1972-05

6.  Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.

Authors:  N Surolia; A Surolia
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

7.  Effect of methyl 2-hexadecynoate on hepatic fatty acid metabolism.

Authors:  R Wood; T Lee; H Gershon
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

8.  Effect of 2-hexadecynoic acid on cultured 7288C hepatoma cells.

Authors:  G C Upreti; M Matocha; R Wood
Journal:  Lipids       Date:  1981-05       Impact factor: 1.880

9.  Structural basis for the variation in triclosan affinity to enoyl reductases.

Authors:  Lakshmi Swarnamukhi Pidugu; Mili Kapoor; Namita Surolia; Avadhesha Surolia; Kaza Suguna
Journal:  J Mol Biol       Date:  2004-10-08       Impact factor: 5.469

10.  Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii.

Authors:  Jane M Carlton; Samuel V Angiuoli; Bernard B Suh; Taco W Kooij; Mihaela Pertea; Joana C Silva; Maria D Ermolaeva; Jonathan E Allen; Jeremy D Selengut; Hean L Koo; Jeremy D Peterson; Mihai Pop; Daniel S Kosack; Martin F Shumway; Shelby L Bidwell; Shamira J Shallom; Susan E van Aken; Steven B Riedmuller; Tamara V Feldblyum; Jennifer K Cho; John Quackenbush; Martha Sedegah; Azadeh Shoaibi; Leda M Cummings; Laurence Florens; John R Yates; J Dale Raine; Robert E Sinden; Michael A Harris; Deirdre A Cunningham; Peter R Preiser; Lawrence W Bergman; Akhil B Vaidya; Leo H van Lin; Chris J Janse; Andrew P Waters; Hamilton O Smith; Owen R White; Steven L Salzberg; J Craig Venter; Claire M Fraser; Stephen L Hoffman; Malcolm J Gardner; Daniel J Carucci
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

View more
  11 in total

1.  2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.

Authors:  Néstor M Carballeira; Michelle Cartagena; David Sanabria; Deniz Tasdemir; Christopher F Prada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Bioorg Med Chem Lett       Date:  2012-08-10       Impact factor: 2.823

2.  Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.

Authors:  Ina L Lauinger; Livia Vivas; Remo Perozzo; Christopher Stairiker; Alice Tarun; Mire Zloh; Xujie Zhang; Hua Xu; Peter J Tonge; Scott G Franzblau; Duc-Hung Pham; Camila V Esguerra; Alexander D Crawford; Louis Maes; Deniz Tasdemir
Journal:  J Nat Prod       Date:  2013-06-19       Impact factor: 4.050

3.  A potent plant-derived antifungal acetylenic acid mediates its activity by interfering with fatty acid homeostasis.

Authors:  Tao Xu; Siddharth K Tripathi; Qin Feng; Michael C Lorenz; Marsha A Wright; Melissa R Jacob; Melanie M Mask; Scott R Baerson; Xing-Cong Li; Alice M Clark; Ameeta K Agarwal
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Antibacterial activity of 2-alkynoic fatty acids against multidrug-resistant bacteria.

Authors:  David J Sanabria-Ríos; Yaritza Rivera-Torres; Gamalier Maldonado-Domínguez; Idializ Domínguez; Camille Ríos; Damarith Díaz; José W Rodríguez; Joanne S Altieri-Rivera; Eddy Ríos-Olivares; Gabriel Cintrón; Nashbly Montano; Néstor M Carballeira
Journal:  Chem Phys Lipids       Date:  2013-12-21       Impact factor: 3.329

5.  2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.

Authors:  Néstor M Carballeira; Angela Gono Bwalya; Maurice Ayamba Itoe; Adriano D Andricopulo; María Lorena Cordero-Maldonado; Marcel Kaiser; Maria M Mota; Alexander D Crawford; Rafael V C Guido; Deniz Tasdemir
Journal:  Bioorg Med Chem Lett       Date:  2014-07-24       Impact factor: 2.823

6.  Antibacterial Activity of Hexadecynoic Acid Isomers toward Clinical Isolates of Multidrug-Resistant Staphylococcus aureus.

Authors:  David J Sanabria-Ríos; Christian Morales-Guzmán; Joseph Mooney; Solymar Medina; Tomás Pereles-De-León; Ashley Rivera-Román; Carlimar Ocasio-Malavé; Damarith Díaz; Nataliya Chorna; Néstor M Carballeira
Journal:  Lipids       Date:  2020-01-24       Impact factor: 1.880

Review 7.  Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids.

Authors:  Néstor M Carballeira
Journal:  Chem Phys Lipids       Date:  2013-05-28       Impact factor: 3.329

Review 8.  Mediterranean Diet: Lipids, Inflammation, and Malaria Infection.

Authors:  Adriana R Silva; Bianca P T Moraes; Cassiano F Gonçalves-de-Albuquerque
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

9.  Synthetic Fatty Acids Prevent Plasmid-Mediated Horizontal Gene Transfer.

Authors:  María Getino; David J Sanabria-Ríos; Raúl Fernández-López; Javier Campos-Gómez; José M Sánchez-López; Antonio Fernández; Néstor M Carballeira; Fernando de la Cruz
Journal:  MBio       Date:  2015-09-01       Impact factor: 7.867

10.  Tanzawaic Acids, a Chemically Novel Set of Bacterial Conjugation Inhibitors.

Authors:  María Getino; Raúl Fernández-López; Carolina Palencia-Gándara; Javier Campos-Gómez; Jose M Sánchez-López; Marta Martínez; Antonio Fernández; Fernando de la Cruz
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.